Nabi Biopharmaceuticals (NABI) Reports Q1 Loss of $0.03/Share

Nabi Biopharmaceuticals (NASDAQ: NABI) reported Q1 EPS of ($0.03), versus $0.05 reported last year. Revenue for the quarter came in at $600 thousand, versus $9.17 million reported last year.

For earnings history and earnings-related data on Nabi Biopharmaceuticals (NABI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Bernstein SocGen: 'We view AI as a significant long-term opportunity for UnitedHealth Group (UNH)'
• Vivakor projects $270M in Q3 2026 revenue from crude oil marketing